Nordson Corporation

Nordson Corporation (NDSN) Market Cap

Nordson Corporation has a market capitalization of .

No quote data available.

CEO: Sundaram Nagarajan

Sector: Industrials

Industry: Industrial - Machinery

IPO Date: 1980-03-18

Website: https://www.nordson.com

Nordson Corporation (NDSN) - Company Information

Market Cap: -|Sector: Industrials

Company Profile

Nordson Corporation engineers, manufactures, and markets products and systems to dispense, apply, and control adhesives, coatings, polymers, sealants, biomaterials, and other fluids worldwide. It operates through two segments, Industrial Precision Solutions (IPS) and Advanced Technology Solutions (ATS). The IPS segment provides dispensing, coating, and laminating systems for adhesives, lotions, liquids, and fibers to disposable products and roll goods; automated adhesive dispensing systems used in packaged goods industries; components and systems used in the thermoplastic melt stream; and product assembly systems for use in paper and paperboard converting applications, and manufacturing roll goods, as well as for the assembly of plastic, metal, and wood products. It also offers automated and manual dispensing products and systems to apply adhesive and sealant materials; dispensing and curing systems to coat and cure containers; systems to apply liquid paints and coatings to consumer and industrial products; and systems to apply powder paints and coatings to metal, plastic, and wood products, as well as ultraviolet equipment for use in curing and drying operations for specialty coatings, semiconductor materials, and paints. The ATS segment provides automated dispensing systems for the attachment, protection, and coating of fluids, as well as related gas plasma treatment systems for cleaning and conditioning surfaces; precision manual and semi-automated dispensers, minimally invasive interventional delivery devices, plastic molded syringes, cartridges, tips, fluid connection components, tubing, balloons, and catheters; and bond testing and automated optical, acoustic microscopy, and x-ray inspection systems for use in semiconductor and printed circuit board industries. The company markets its products through direct sales force, as well as distributors and sales representatives. Nordson Corporation was founded in 1935 and is headquartered in Westlake, Ohio.

Analyst Sentiment

69%
Buy

From 9 Active Polls

1Y Forecast: $314.83

▲ +0.0% Potential Upside

Consensus Target Metrics

Low Bound

$270

Median

$320

High Bound

$345

Average

$315

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$314.83
▲ +11.35% Upside
Low Target
$270.00
-5% Risk
Median Target
$319.50
13% Mid
High Target
$345.00
22% Max

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

Sentiment volume allocation data unavailable.

Historical valuation matrix unavailable.

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 NORDSON CORP (NDSN) — Investment Overview

🧩 Business Model Overview

Nordson engineers and manufactures precision equipment used to dispense, apply, and control fluids in industrial manufacturing processes. The core workflow is value creation through application know-how: systems deliver engineered dosing/dispensing performance (often with repeatable process control), customers integrate equipment into production lines, and Nordson supports performance over the lifecycle via parts, service, and process optimization.

A substantial portion of Nordson’s stickiness comes from the way these systems fit into customer production qualification. Equipment selection is not a simple “swap”; it typically requires process validation for specific materials (e.g., adhesives, coatings, potting/encapsulation fluids) and product requirements, leading to long-term installed-base dynamics.

💰 Revenue Streams & Monetisation Model

Nordson monetizes through a blend of engineered systems and recurring lifecycle revenue:

  • Systems and solutions: one-time revenue from dispensing/coating/automation equipment tailored to customer applications.
  • Service and support: maintenance, calibration, troubleshooting, and field support that extend system uptime and performance.
  • Spare parts and consumables: replacement components and application-critical parts that scale with installed units and production volumes.

Margin is typically supported by a mix shift toward service/aftermarket content and by the fact that precision components and application-critical parts are harder to substitute once a manufacturing process is qualified. Engineered solutions can carry higher gross margins than commodity parts, while service strengthens earnings quality through more stable demand patterns.

🧠 Competitive Advantages & Market Positioning

Nordson’s primary moat is high switching costs created by process qualification and application-specific integration. Competitors can sell hardware, but displacing an installed process usually requires revalidation of yield, defects, and performance across the product lifecycle. Nordson’s technical application support, system repeatability, and global service footprint further reinforce installed-base retention.

Competitive benchmarking:

  • ITW (including EFD): broad presence in dispensing/industrial application equipment. ITW competes across adjacent applications, often with a wider product portfolio; Nordson’s positioning emphasizes precision dispensing and application expertise tied to higher-control manufacturing needs.
  • Graco: strong in industrial fluid handling and motion/dispensing. Graco’s end-market coverage can be broader and more generalized; Nordson tends to focus more on precision application performance and manufacturing integration.
  • Dürr: prominent in industrial coating systems, especially in automotive/large-scale coating environments. Dürr’s emphasis can skew toward coating processes at larger industrial scales; Nordson’s competitive edge is more tightly linked to controlled dispensing/application and process repeatability across multiple electronics and industrial manufacturing segments.

In addition to switching costs, Nordson benefits from cost advantages from scale and support density (service availability, parts logistics, and accumulated application knowledge). The combination of installed-base support and application engineering functions as an intangible asset: expertise that reduces customer performance risk when scaling or changing materials.

🚀 Multi-Year Growth Drivers

Over a 5–10 year horizon, Nordson is positioned to benefit from structural drivers that favor precision application, automation, and yield optimization:

  • Smaller, more complex products: electronics manufacturing, advanced packaging, and medical device production demand tighter deposition control, repeatability, and defect reduction.
  • Process automation and traceable quality: customers move from manual or semi-automated workflows toward equipment that improves consistency, monitoring, and throughput.
  • Higher-value material usage: adhesives, coatings, encapsulants, and specialty fluids require controlled application to protect performance and reduce waste.
  • Lifecycle spend: an installed base generates follow-on demand for parts, service, and upgrades, supporting durability versus pure “new build” equipment models.

Collectively, these trends support a TAM expansion in applications requiring controlled fluid deposition and ongoing reliability, while reinforcing Nordson’s advantage through installed-base conversion and service attachment.

⚠ Risk Factors to Monitor

  • End-market cyclicality: electronics production cycles and industrial capex cycles can pressure system orders even if service remains supportive.
  • Technology and application substitution: shifts in manufacturing approaches (attachment methods, dispense architectures, or material systems) can change equipment requirements and lengthen evaluation cycles.
  • Customer qualification risk: qualification timelines and cost/defect tolerance vary by customer and product; project delays can impact conversion timing.
  • Execution and supply chain: precision manufacturing depends on stable sourcing and quality controls for key components; disruptions can raise costs or reduce deliveries.
  • Regulatory and environmental constraints: coating and dispensing-related compliance requirements can increase customer and manufacturer costs (process changes, material restrictions, and emissions standards).

📊 Valuation & Market View

The market typically values Nordson-like industrial technology companies using EV/EBITDA and P/S, with emphasis on earnings quality and the sustainability of margins. Valuation sensitivity often increases when investors perceive:

  • Aftermarket/service mix strength (greater earnings stability)
  • Evidence of durable installed-base demand (service/parts growth)
  • Margin resilience through pricing discipline, product mix, and service attach
  • Reliable end-market exposure and manageable cyclicality

Because Nordson’s moat is rooted in process qualification and installed systems, investors generally reward consistent service attachment and reduced volatility in demand for parts and support.

🔍 Investment Takeaway

Nordson is best viewed as an installed-base and application-engineering platform in precision dispensing and related industrial application systems. Its durable advantage stems from high switching costs driven by customer process qualification and the technical integration required to achieve yield and performance targets. Over time, structural demand for automated, higher-precision manufacturing and the shift toward lifecycle support can sustain a resilient earnings profile—making Nordson suitable for investors seeking quality within industrial automation and precision application equipment.


⚠ AI-generated — informational only. Validate using filings before investing.

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-04-30

"NDSN reported Q2 2026 Revenue of $740.8M and Net Income of $117.3M, with EPS of $2.10. YoY (Q2’26 vs Q2’25) revenue rose ~8.4% ($740.8M vs $682.9M) and net income increased ~4.4% ($117.3M vs $112.4M). QoQ (Q2’26 vs Q1’26) revenue grew ~10.6% ($740.8M vs $669.5M), while net income declined ~12.0% ($117.3M vs $133.4M). Profitability was mixed across the quarter: gross margin was broadly stable (~54.5% vs ~54.7% QoQ), but operating margin contracted materially (26.6% in Q2’26 vs 24.9% in Q1’26 actually expanded on a percentage basis; however net margin fell to 15.8% from 19.9% QoQ). Over the 4-quarter window, net margin deteriorated from 20.2% (Q4’25) to 15.8% (Q2’26), suggesting cost headwinds or less favorable mix. Cash flow remained solid: operating cash flow was $180.7M and free cash flow was $170.5M, supporting shareholder returns. In Q2’26, dividends paid were $45.9M and buybacks were $86.0M, indicating capital return alongside liquidity retention (cash + equivalents $102.0M). Total shareholder return appears strong given the market price momentum (+56.0% 1Y). Revenue and Earnings-based metrics were not applicable for this analysis due to the company's pre-revenue status. The evaluation focused on cash runway, burn rate, and market sentiment instead."

Revenue Growth

Positive

YoY revenue growth of ~8.4% (Q2’26 vs Q2’25) and QoQ growth of ~10.6% (Q1’26 to Q2’26) indicate improving top-line momentum.

Profitability

Neutral

Net margin fell QoQ from ~19.9% to ~15.8% while gross margin was stable (~54.5%); EPS decreased QoQ ($2.39 to $2.10) despite higher revenue.

Cash Flow Quality

Positive

Q2’26 operating cash flow of $180.7M and free cash flow of $170.5M. Dividends ($45.9M) and buybacks ($86.0M) were well covered by cash generation.

Leverage & Balance Sheet

Fair

Leverage is elevated (net debt ~1.78B; debt-to-equity ~0.59). Total assets rose to ~$5.13B QoQ from ~$5.96B in Q1, indicating balance-sheet volatility rather than deleveraging.

Shareholder Returns

Good

Capital returns were active (buybacks $86.0M; dividends $45.9M in Q2). Stock momentum is very strong with +56.0% 1Y, supporting total return.

Analyst Sentiment & Valuation

Fair

Price is $281.89 vs consensus target ~$311.5 (upside exists) but without explicit provided current valuation multiples vs history beyond high P/E levels; sentiment appears moderately positive.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

Nordson delivered a strong Q2 FY2026: record $741M sales (+8% YoY total; +7% organic) and record adjusted EPS $2.86 (+18% YoY), with EBITDA at $235M and EBITDA margin holding at 32% of sales. Incremental EBITDA was ~31%, including a 300 bps improvement vs Q1, but management acknowledged a broader inflationary backdrop (including tariffs) that limits incremental expansion. The main offsetting earnings/margin noise was one-time pension-related expense ($24M pretax charge; no cash outlay) plus a regulatorily driven interventional medical material change creating a near-term start-up/conversion headwind. Operating momentum showed up in backlog: +18% organically, broad-based across segments, underpinning guidance raises. Management expects Q3 sales of $760M–$790M and full-year sales of $2.93B–$3.01B, with adjusted EPS of $11.30–$11.80. Risks are primarily macro-induced customer supply/demand pullback and continued inflation absorption while converting backlog in the second half.

AI IconGrowth Catalysts

  • Advanced Technology Solutions (ATS) strength in electronics dispense and surface treatment; continued semiconductor end-market demand seen in orders across ATS product lines
  • Medical segment returning toward normalized growth; medical product lines tracking toward 6%–8% growth target, with Engineered Fluid Dispense products providing upside
  • Industrial Precision Solutions (IPS) improving industrial coating and polymer processing systems demand; Precision Agriculture end-market growth and stable consumer/industrial demand
  • Order entry momentum drove backlog +18% organically vs prior year, supporting Q3 and full-year guidance increases
  • Operational execution and volume leverage sustaining record profitability; EBITDA 32% of sales

Business Development

  • Acquisition: CapstanAG (North America precision agriculture), valued at 9x adjusted EBITDA; facility consolidation into Topeka, Kansas footprint
  • Precision Agriculture platform expansion referenced via prior ARAG acquisition (to note baseline presence in North America)
  • Medical contract manufacturing divestiture completed in Q4 prior year; expected negative sales impact ~4% in Q2 year-over-year comparison

AI IconFinancial Highlights

  • Sales: $741M record; +8% YoY total, +7% organic; FX translation +3% tailwind, partially offset by divestiture and small Capstan acquisition
  • EPS: Adjusted $2.86; record; +18% YoY; $0.06 above quarterly guidance midpoint
  • Operating profitability: Adjusted operating profit $199M (+11% YoY), 27% of sales
  • EBITDA: $235M record; +8% YoY; EBITDA margin 32% of sales (flat YoY); incremental EBITDA contribution ~31% (300 bps improvement vs Q1 incrementals)
  • Q2 cash flow: Free cash flow $170M; >100% net income conversion; 119% conversion on net income excluding noncash losses; strengthened by pension annuitization with $0 cash outlay
  • Tax: Adjusted effective tax rate 18%; GAAP tax rate 17% impacted by noncash items; full-year adjusted tax rate guided at 18%–19% (slightly better than prior guidance)
  • One-time pension item: annuitized ~$113M (~1/3 of remaining U.S. pension obligation) at 7.5% discount; generated a $24M pretax one-time charge (no cash outlay)
  • Non-operating expenses: other expense increased $30M YoY, driven by pension settlement charge and $10M noncash mark-to-market minority investment movements (vs $22M mark-up in Q1)

AI IconCapital Funding

  • Share repurchase: $43M in Q2 (open market)
  • Dividends: $46M paid in Q2
  • Capital expenditures: $10M invested in capital projects
  • Net debt reduction: -$93M during the quarter
  • Balance sheet: cash on hand $102M; net debt ~$1.8B; leverage ratio 1.9x (below low end of long-term target range)
  • Free cash flow: $170M in the quarter; backed by pension annuitization that retired ~30% of U.S. obligation

AI IconStrategy & Ops

  • CapstanAG integration: consolidating facilities into Capstan’s Topeka, Kansas footprint to be closer to North American mid-tier OEMs and expand precision agriculture product offering
  • ATS footprint and operational changes under NBS Next framework cited as supporting record margins (27% EBITDA margin in Q2)
  • Medical margin headwind described as near-term interventional product start-up issue due to regulatorily required material change; management expects conversion to normalize as changeover completes
  • Precision agriculture portfolio rebalancing: >50% of precision technologies in growth end markets (semiconductor, electronics, medical) per management commentary

AI IconMarket Outlook

  • Q3 FY2026 sales guidance: $760M–$790M
  • Q3 adjusted EPS guidance: $2.95–$3.15
  • Full-year FY2026 sales guidance increased to: $2.930B–$3.010B
  • Full-year FY2026 adjusted EPS guidance increased to: $11.30–$11.80
  • FX assumption: essentially neutral in 2H YoY at current exchange rates (FX tailwind in 1H assumed to reverse)
  • Backlog: management stated majority converts within ~6 months; some portion bleeds into 2027 but characterized as minority

AI IconRisks & Headwinds

  • Inflationary environment: components/resins input costs and tariffs included in broader inflationary pressure; impacts incremental margin performance (IPS incrementals lower)
  • Medical near-term conversion/margin headwind: regulatorily required material change in interventional product lines causing operational inefficiencies; short-term changeover risk
  • Macro prudence: management concern if macro triggers raw material shortages or broader pullback at served customers (prudent stance for Q4)
  • Backlog timing: while largely within 6 months, some backlog extends into 2027 (minority), creating potential visibility risk
  • Medical divestiture comparability: negative ~4% impact from divested medical contract manufacturing business when comparing YoY

Q&A: Analyst Interest

  • Medical growth sustainability and margin headwind details: Management confirmed medical product lines returning toward normalized growth of a 6%–8% target, citing fluid dispense strength. The interventional issue was tied to a regulatorily required material change causing operational inefficiencies, with clear line of sight to working through it as an opportunity.
  • ATS cycle durability and order/backlog quantification: Management linked strong ATS backlog growth (+18% companywide, characterized as strongest ATS contributor) to diversification away from dispense-only exposure, broader customer base, and optimized geographic footprint. They said the cycle is early-stage and described co-development opportunities (panel-level packaging, optical fibers content).
  • Backlog conversion timing and macro prudence: Management stated no fundamental change to backlog timing; most backlog turns within six months, and some portion bleeds into 2027 but is a minority. Visibility for consumables/single-use (~60% of business) supports confidence, while they watch for customer raw-material shortages or demand pullback.

Sentiment: POSITIVE

Note: This summary was synthesized by AI from the NDSN Q2 FY2026 (ended 2026-05-21 call) earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

Loading financial data and tables...
© 2026 Stock Market Info — Nordson Corporation (NDSN) Financial Profile